YORVIPATH launching in U.S. with product availability expected mid-January 2025; ex-U.S. YORVIPATH revenue of €8.5 million in Q3– TransCon CNP ...
At the heart of the agreement is an exclusive worldwide license to Copenhagen-based Ascendis' TransCon technology platform, which involves adding linker and carrier molecules to turn established ...
Ascendis Pharma (ASND) Company Description: Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. Through its TransCon technology, it develops a ...
Their work can help to lower the ... The Evolution of Green Energy Technology: Developing Three-Dimensional Smart Energy Devices With Radiant Cooling and Solar Absorption Oct. 25, 2024 — - DGIST ...
This strategy does not shy away from expensive stocks, and it usually finds them in the technology sector. The portfolio’s price/earnings, price/sales, and price/cash flow ratios are generally ...
COPENHAGEN - Ascendis Pharma A/S (NASDAQ:ASND) has reported encouraging outcomes from its ongoing Phase 1/2 IL-Believe Trial, evaluating TransCon IL-2 β/γ therapy for ...
Nov. 12, 2024 — The chances of intelligent life emerging in our Universe -- and in any hypothetical ones beyond it -- can be estimated by a new theoretical model ...
What China is doing to make ports ‘smart’ and not prone to work stoppages A unit of state-owned China Merchants Group is pushing a range of automation and digital technologies to make ports ...
While most people are distracted by technology, including when they drive, society can work towards achieving a distraction-free future. Enforcement of regulations and laws covering distracted ...
'Metaphor ReFantazio' is certainly in the running for Game of the Year, and is a must-play for RPG fans ...
The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback